Skip to content

6-K/AAccepted Oct 16, 4:31 PM ET

NERVGEN PHARMA CORP. 6-K/A

NGENNERVGEN PHARMA CORP.

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

4:31 PM

Oct 16, 2026

Filed

Oct 16, 2026

Documents

9

Size

1.2 MB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.